The aminosilane-modified FMNPs were separated by permanent magnet and were washed with deionized water three times then redispersed the FMNPs-NH2 in 100 mL dimethylformamide (DMF) and added with excess succinic anhydride to form a mixed solution and react at room temperature for 24 h. The carboxyl-modified FMNPs were separated by permanent magnet again and washed with deionized water three times. Preparation and characterization of HAI-178 monoclonal antibody-conjugated FMNPs We used a two-step process to obtain stable HAI-178-antibody-FMNPs conjugation. Solution of 1.5 mg FMNPs-COOH was dispersed

in 2 mL pH 7 PBS buffer and was sonicated for 10 min. Then we mixed 1 mL of fresh 400 mM EDC and 100 mM NHSS in pH 6.0 MES buffer and rotated mTOR inhibitor it at room temperature for 15 min. After this, the resulting solution was separated by magnetic field, and 1 mg/mL of HAI-178 monoclonal antibody was added to the above mixture and stirred in dark place for 2 h. To remove free HAI-178 antibody, the residual reaction mixture was separated by magnetic field and the solid Tanespimycin mouse remaining was

washed with 1 mL of PBS buffer three times. Finally, 1 mL of 0.05% Tween-20/PBS was added to the HAI-178 antibody-FMNPs conjugation and the bioconjugation was stored at 4°C. When used, this HAI-178 antibody-FMNPs conjugation should be diluted with PBS/0.05% Tween-20. Then we used the Nano Drop device to quantify the coupling rate of HAI-178 antibody with FMNPs-COOH. Before the coupling reaction, we measured the total concentration of HAI-178 antibody. After the coupling reaction, we measured the HAI-178 antibody concentration in residual reaction mixture and calculated the coupling rate according the equation: Coupling (%) = (1 − Concentration 3-mercaptopyruvate sulfurtransferase of HAI-178 antibody in residual reaction mixture/Total concentration of HAI-178 antibody) × 100. The as-prepared nanoprobes and pure FMNPs were characterized by transmission electron microscopy, photoluminescence

(PL) spectrometry, and fluorescent microscopy. Nanoprobes for in vitro targeting imaging of gastric cancer cells Gastric cancer cell line MGC803 cells with over-expression of α-subunit of ATP synthase were used as CH5183284 molecular weight target cells, and human gastric mucous GES-1 cells without expression of α-subunit of ATP synthase was used as control. The cells were cultured and collected, then were treated with 50 μg/mL HAI-178 antibody-conjugated FMNPs nanoprobes, and cultured in a humidified 5% CO2-balanced air incubator at 37°C for 4 h. Meanwhile, the MGC803 and GES-1 cells were treated with FMNPs as the control group. Afterward, the cells were rinsed with PBS three times, and then the cells were fixed with 2.5% glutaraldehyde solution for 30 min. For nuclear counterstaining, MGC803 cells were incubated with 1 mM Hoechst 33258 (Invitrogen, Life Technologies, Carlsbad, CA, USA) in PBS for 5 min.